IL134368A - Temperature - controlled ph - dependent formation of ionic gels based on chitosan or derivatives thereof - Google Patents

Temperature - controlled ph - dependent formation of ionic gels based on chitosan or derivatives thereof

Info

Publication number
IL134368A
IL134368A IL13436898A IL13436898A IL134368A IL 134368 A IL134368 A IL 134368A IL 13436898 A IL13436898 A IL 13436898A IL 13436898 A IL13436898 A IL 13436898A IL 134368 A IL134368 A IL 134368A
Authority
IL
Israel
Prior art keywords
chitosan
temperature
phosphate
organo
aqueous
Prior art date
Application number
IL13436898A
Other languages
English (en)
Other versions
IL134368A0 (en
Original Assignee
Biosyntech Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosyntech Canada Inc filed Critical Biosyntech Canada Inc
Publication of IL134368A0 publication Critical patent/IL134368A0/xx
Publication of IL134368A publication Critical patent/IL134368A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/008—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Physical Vapour Deposition (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
IL13436898A 1997-08-04 1998-04-06 Temperature - controlled ph - dependent formation of ionic gels based on chitosan or derivatives thereof IL134368A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002212300A CA2212300A1 (en) 1997-08-04 1997-08-04 In vitro or in vivo gelfying chitosan and therapeutic uses thereof
PCT/CA1998/000326 WO1999007416A1 (en) 1997-08-04 1998-04-06 TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS

Publications (2)

Publication Number Publication Date
IL134368A0 IL134368A0 (en) 2001-04-30
IL134368A true IL134368A (en) 2005-09-25

Family

ID=4161194

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13436898A IL134368A (en) 1997-08-04 1998-04-06 Temperature - controlled ph - dependent formation of ionic gels based on chitosan or derivatives thereof

Country Status (14)

Country Link
US (1) US6344488B1 (xx)
EP (1) EP1003567B1 (xx)
JP (1) JP3634748B2 (xx)
AT (1) ATE246524T1 (xx)
AU (1) AU724878B2 (xx)
CA (1) CA2212300A1 (xx)
DE (1) DE69816996T2 (xx)
DK (1) DK1003567T3 (xx)
ES (1) ES2205471T3 (xx)
IL (1) IL134368A (xx)
NO (1) NO330580B1 (xx)
NZ (1) NZ502919A (xx)
PT (1) PT1003567E (xx)
WO (1) WO1999007416A1 (xx)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767452B2 (en) 1997-02-20 2010-08-03 Kleinsek Don A Tissue treatments with adipocyte cells
US6245740B1 (en) * 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
FR2799371A1 (fr) * 1999-10-12 2001-04-13 Univ Paris Curie Compositions de tenocytes preparation et utilisations
AU1472501A (en) * 1999-11-05 2001-05-14 Gerigene Medical Corporation Augmentation and repair of age-related soft tissue defects
AU2005202256B2 (en) * 1999-11-05 2008-04-03 Gerigene Medical Corporation Augmentation and repair of age-related soft tissue defects
EP1229940B1 (en) 1999-11-15 2014-05-14 Piramal Healthcare (Canada) Limited Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
AU1792601A (en) * 1999-12-07 2001-06-18 Amgen, Inc. Thermosensitive biodegradable hydrogels based on low molecular weight pluronics
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
EP1255576B1 (en) * 1999-12-09 2003-08-20 Biosyntech Canada Inc. Mineral-polymer hybrid composition
PT1276486E (pt) 2000-04-25 2011-02-07 Osiris Therapeutics Inc Reparação de articulação utilizando células estaminais do mesênquima
KR100880622B1 (ko) * 2000-06-29 2009-01-30 바이오신텍 캐나다 인코포레이티드 연골 및 다른 조직의 복구 및 재생용 조성물 및 방법
WO2002040070A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
AU2002220396A1 (en) * 2000-11-15 2002-05-27 Bio Syntech Canada Inc Filler composition for soft tissue augmentation and reconstructive surgery
US6989373B2 (en) * 2000-11-15 2006-01-24 Bio Syntech Canada Inc. Method for restoring a fat-pad
US7449180B2 (en) * 2001-02-06 2008-11-11 John Kisiday Macroscopic scaffold containing amphiphilic peptides encapsulating cells
WO2003037165A2 (en) 2001-11-01 2003-05-08 Boyd Lawrence M System and method for the pretreatment of the endplates of an intervertebral disc
AU2002336694A1 (en) 2001-11-01 2003-05-12 Lawrence M. Boyd Devices and methods for the restoration of a spinal disc
TWI245634B (en) * 2001-12-28 2005-12-21 Ind Tech Res Inst Preparation of a biodegradable thermal-sensitive gel system
NZ535270A (en) 2002-03-12 2006-11-30 Univ Montreal Composition having gelling properties for the sustained delivery of bioactive substances
US20050031650A1 (en) * 2002-08-26 2005-02-10 Ethypharm Composition with gelling properties for the sustained delivery of bioactive substances
AU2002330762B2 (en) * 2002-09-30 2007-08-09 Regen Biotech, Inc. Composition for stimulating bone-formation and bone consolidation
AU2003287812A1 (en) * 2002-12-03 2004-06-23 Bio Syntech Canada Inc. Method for treating a tumor using a thermo-gelling chitosan composition
ES2440654T3 (es) 2003-05-05 2014-01-29 Ben-Gurion University Of The Negev Research And Development Authority Preparaciones poliméricas reticuladas inyectables y usos de las mismas
US7524514B2 (en) 2003-12-01 2009-04-28 Tissue Engineering Consultants, Inc. Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
US8835514B2 (en) 2004-03-22 2014-09-16 Laboratoire Medidom S.A. Pseudo-thermosetting neutralized chitosan composition forming a hydrogel and a process for producing the same
US20050255161A1 (en) * 2004-05-10 2005-11-17 Servet Buyuktimkin Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water
US7837733B2 (en) * 2004-06-29 2010-11-23 Spine Wave, Inc. Percutaneous methods for injecting a curable biomaterial into an intervertebral space
US8512730B2 (en) * 2004-07-12 2013-08-20 Isto Technologies, Inc. Methods of tissue repair and compositions therefor
WO2006033698A2 (en) * 2004-07-12 2006-03-30 Isto Technologies, Inc. Tissue matrix system
DK1759711T3 (da) * 2005-09-02 2008-10-27 Jordanian Pharmaceutical Mfg Chitosan/siliciumdioxid.copræcipitat og anvendelse som excipiens i faste doseringsformer
EP1948810A4 (en) * 2005-11-04 2010-06-30 Biosyntech Canada Inc COMPOSITION AND METHOD USING CHITOSAN FOR THE EFFICIENT ADMINISTRATION OF NUCLEIC ACIDS TO CELLS
EP1945712A4 (en) * 2005-11-04 2013-05-01 Piramal Healthcare Canada Ltd BINDING OF AQUEOUS POLYELECTROLYTE SOLUTIONS BY THERMALLY INDUCED CHANGES IN THE IONIZATION CONDITION
ES2528272T3 (es) * 2005-12-07 2015-02-06 Isto Technologies Inc. Métodos de reparación de cartílago
SI1978925T1 (sl) * 2005-12-23 2010-01-29 Medidom Lab Termoreaktiven nevtraliziran sestavek hitozana, ki tvori hidrogel, liofilizat in postopek za izdelavo le-tega
WO2007087350A2 (en) * 2006-01-25 2007-08-02 University Of Virginia Patent Foundation Methods for regulating gelation of polysaccharide solutions and uses thereof
FR2897775B1 (fr) * 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
WO2007123993A2 (en) * 2006-04-19 2007-11-01 University Of South Florida Niosome-hydrogel drug delivery
ITPD20060203A1 (it) * 2006-05-22 2007-11-23 Univ Degli Studi Trieste Idrogeli di miscele di polisaccaridi per l'ingegneria tissutale e la veicolazione di composti attivi
US8153612B2 (en) 2006-12-11 2012-04-10 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
EP2121026B1 (en) * 2006-12-11 2017-06-28 CHIT2GEL Ltd. Novel injectable chitosan mixtures forming hydrogels
US9034348B2 (en) 2006-12-11 2015-05-19 Chi2Gel Ltd. Injectable chitosan mixtures forming hydrogels
ITMI20062513A1 (it) * 2006-12-27 2008-06-28 Univ Parma Composizioni di gel stabili citocompatibili adatti a fungere da supporto per la crescita cellulare
EP2476411A1 (en) * 2007-03-13 2012-07-18 Biolinerx Ltd. A method of promoting tissue repair
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
DE102007034580B4 (de) 2007-07-13 2012-11-08 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Biomaterial basierend auf einem hydrophilen polymeren Träger
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
WO2009076369A1 (en) * 2007-12-10 2009-06-18 The Trustees Of The University Of Pennsylvania Chitosan-based matrices and uses thereof
CL2008000156A1 (es) 2008-01-18 2008-08-01 Igloo Zone Chile S A Gel estable hidrofilo en base a un polimero para aplicacion topica porque comprende quitosano disuelto en un solvente; proceso para obtener el gel para uso topico antes mencionado; uso del gel.
DE102008008071A1 (de) 2008-01-28 2009-08-06 NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen Injizierbare biokompatible Zusammensetzung
AU2009240512B2 (en) 2008-04-24 2014-07-10 Medtronic, Inc. Protective gel based on chitosan and oxidized polysaccharide
US8802652B2 (en) 2008-04-24 2014-08-12 Medtronic, Inc. Rehydratable polysaccharide particles and sponge
AU2009240509B2 (en) 2008-04-24 2014-08-21 Medtronic, Inc. Rehydratable thiolated polysaccharide particles and sponge
US8530632B2 (en) 2008-04-24 2013-09-10 Medtronic Xomed, Inc. Chitosan-containing protective composition
EP2294126A1 (en) * 2008-06-11 2011-03-16 Chi2Gel Ltd. Injectable hydrogel forming chitosan mixtures
EP3545979A1 (en) * 2008-07-02 2019-10-02 Allergan, Inc. Compositionsand methods for tissue filling and regeneration
US20110229565A1 (en) 2008-09-17 2011-09-22 Karp Jeffrey M Drug Delivery Composition Comprising a Self-Assembled Gelator
EP2352505B1 (en) 2008-11-04 2016-07-06 University Of Kentucky Research Foundation D-tagatose-based compositions and methods for preventing and treating atherosclerosis, metabolic syndrome, and symptoms thereof
WO2011026498A1 (en) 2009-09-01 2011-03-10 Medovent Gmbh Chitosan tissue dressing
US8668899B2 (en) 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
WO2011060553A1 (en) * 2009-11-19 2011-05-26 Corporation De L'ecole Polytechnique De Montreal Formulation and method for rapid preparation of isotonic and cytocompatible chitosan solutions without inducing chitosan precipitation
WO2011060554A1 (en) * 2009-11-19 2011-05-26 Corporation De L'ecole Polytechnique De Montreal Presolidified composition and method for in situ delivery of broad molecular weight range of chitosan implants with or without therapeutics for regenerative medicine and cartilage repair applications
CA2814784C (en) 2009-11-19 2022-07-26 Corporation De L'ecole Polytechnique De Montreal Soluble physiological chitosan formulations combined with platelet-rich plasma (prp) for tissue repair
US8623403B2 (en) * 2009-12-02 2014-01-07 University Of Virginia Patent Foundation Methods for regulating gelation of hydrogel solutions and uses thereof
US8840867B2 (en) * 2010-05-20 2014-09-23 Val-Chum Limited Partnership Embolizing sclerosing hydrogel
CN103189435B (zh) * 2010-08-27 2016-02-17 奥利高医疗公司 高度生物相容性的双重热凝胶化脱乙酰壳多糖/氨基葡糖盐组合物
TWI386224B (zh) * 2010-09-07 2013-02-21 Univ Nat Chiao Tung 可注射性智慧凝膠及其製備方法
EP4079292A1 (en) 2010-09-24 2022-10-26 The Brigham and Women's Hospital, Inc. Nanostructured gels capable of controlled release of encapsulated agents
NL2007179C2 (en) * 2011-07-26 2013-01-29 Stichting Katholieke Universiteit Chitosan-based hydrogels containing enzyme alkaline phosphatase.
EP2782603A1 (en) 2011-11-25 2014-10-01 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system
TWI473627B (zh) * 2012-02-17 2015-02-21 Taipei Veterans General Hospital 用於幹細胞療法注射傳輸系統的雙性幾丁質奈米膠
EP2922581B1 (en) 2012-10-25 2017-03-15 Mdt Int'l S.A. Mucoadhesive compositions comprising hyaluronic acid and chitosan for topical application
US10245306B2 (en) 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
CA2925819C (en) 2013-09-30 2021-08-03 Bioactive Regenerative Therapeutics, Inc. Biomimetic hybrid gel compositions and methods of use
US9192692B2 (en) 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan stenting paste
US9192574B2 (en) * 2013-10-24 2015-11-24 Medtronic Xomed, Inc. Chitosan paste wound dressing
AU2014369213B2 (en) * 2013-12-19 2017-10-19 Novartis Ag Drug delivery systems
US9522114B1 (en) 2014-03-27 2016-12-20 University Of South Florida Enhanced targeted drug delivery system via chitosan hydrogel and chlorotoxin
FR3024362A1 (fr) 2014-08-01 2016-02-05 Synolyne Pharma Sa Composition thermogelifiable sterilisee
TWI569809B (zh) * 2014-10-08 2017-02-11 國立交通大學 長效型持續釋放藥物之注射式凝膠組成物及其製備方法
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
US20170360912A1 (en) * 2014-12-17 2017-12-21 Socovar, L.P. Chitosan-based hydrogel and applications thereof.
EP3237654B1 (en) * 2014-12-23 2020-02-12 Koninklijke Philips N.V. System for oral ph change
EA026104B1 (ru) * 2015-04-02 2017-03-31 Общество С Ограниченной Ответственностью "Тектум" Кровоостанавливающее и ранозаживляющее средство
FR3038318B1 (fr) 2015-07-02 2017-08-04 Univ De Lille 1 Sciences Et Technologies Procede de fabrication d'hydrogel a base de chitosan et de polyelectrolytes charges negativement et materiau poreux alveolaire issu dudit hydrogel
FR3038838B1 (fr) 2015-07-13 2017-08-18 Synolyne Pharma Chitosane pour melange avec un fluide coagulable
CN108289833B (zh) 2015-10-08 2022-01-25 布里格姆及妇女医院股份有限公司 用于递送囊封剂的稳定的已组装纳米结构
JP6864001B2 (ja) * 2015-11-03 2021-04-21 ゾエティス・サービシーズ・エルエルシー ゾル−ゲルポリマー組成物及びそれらの使用
US9655842B1 (en) 2015-12-04 2017-05-23 Covidien Lp Injectable non-aqueous compositions and methods of treating vascular disease
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
BR112018068794A2 (pt) * 2016-03-18 2019-04-09 Her Majesty The Queen In Right Of Canada As Represented By The Mini Of Agriculture And Agri Food composição para a prevenção de infecção intramamária e método de prevenção de infecção intramamária
US10568840B2 (en) 2016-05-06 2020-02-25 The Brigham And Women's Hospital, Inc. Self assembled gels for controlled delivery of encapsulated agents to cartilage
US11020410B2 (en) 2017-02-03 2021-06-01 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
JP7123971B2 (ja) * 2017-04-20 2022-08-23 ゾエティス・サービシーズ・エルエルシー 乳腺炎を処置する際に使用する動物用組成物、及び関連方法
AU2018266131B2 (en) 2017-05-08 2021-07-29 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
WO2019094568A1 (en) * 2017-11-09 2019-05-16 Isp Investments Llc Thickener systems for oral care compositions and a method for preparing the same
US10784440B2 (en) 2017-11-10 2020-09-22 Taiwan Semiconductor Manufacturing Co., Ltd. Magnetic random access memory with various size magnetic tunneling junction film stacks
CA3083607A1 (en) 2017-12-01 2019-06-06 Zoetis Services Llc Hydrogel compositions and uses thereof
JP7370560B2 (ja) * 2018-05-29 2023-10-30 公立大学法人大阪 生体活性セメントペーストおよび生体活性セメントを製造するためのキット、生体活性セメントペーストおよびその製造方法
WO2020076453A1 (en) 2018-10-11 2020-04-16 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
CN110180023B (zh) * 2019-06-17 2021-07-13 湖南工业大学 一种高强度生物质组织工程支架材料的制备方法
KR102100506B1 (ko) * 2019-06-27 2020-04-13 주식회사 메디팹 온도 감응성 키토산 하이드로겔 조성물 및 그를 포함하는 바이오 잉크 조성물
CN112442139B (zh) * 2019-08-29 2021-09-03 武汉大学 一种基于弱碱体系均相制备不同壳聚糖衍生物的方法
CN110522947B (zh) * 2019-09-16 2021-04-02 青岛大学 一种4d-壳聚糖温敏凝胶制备方法
CN110935008B (zh) * 2019-12-10 2023-09-26 昆明医科大学第一附属医院 一种关节腔注射治疗骨关节炎的tn14003温敏型凝胶及其制备方法
CN111068116B (zh) * 2019-12-28 2022-03-22 河北柯瑞生物医药有限公司 一种注射用软骨修复温敏凝胶及其制备方法
CN111560244B (zh) * 2020-06-02 2023-08-18 安徽工程大学 一种pH响应的壳聚糖荧光复合胶束及其制备方法和应用
CN111939325B (zh) * 2020-08-14 2022-06-17 深圳市人民医院 一种可注射复合水凝胶及其制备方法和应用
WO2022226633A1 (en) * 2021-04-30 2022-11-03 Oligo Médic Inc. Novel water-soluble chitosan compositions and method to prepare the same
LU503425B1 (en) * 2022-02-11 2023-09-20 Heilongjiang Kaizhenglihua Biological And Chemical Tech Co Ltd Low-cost temperature-sensitive hydrogel for wound treatment and preparation method thereof
CN115193349B (zh) * 2022-06-17 2023-09-26 佳木斯大学 一种多孔空心碳纳米球的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185618A (en) 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4391909A (en) 1979-03-28 1983-07-05 Damon Corporation Microcapsules containing viable tissue cells
SE441009B (sv) * 1982-03-08 1985-09-02 Kjell Nilsson Sett att immobilisera levande biomaterial i perlformiga polymerer
US4474769A (en) 1983-05-13 1984-10-02 Pfanstiehl Laboratories, Inc. Chitosan as a contraceptive
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
US5126141A (en) * 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5073202A (en) * 1989-03-09 1991-12-17 Micro Vesicular Systems, Inc. Method of using a biodegradable superabsorbing sponge
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5266326A (en) 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
US5871985A (en) * 1992-09-28 1999-02-16 Brown University Research Foundation Particulate non cross-linked chitosan core matrices for encapsulated cells
CA2130295A1 (en) * 1993-08-26 1995-02-27 Richard A. Berg Ionically crosslinked glycosaminoglycan gels for soft tissue augmentation and drug delivery
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
ATE258810T1 (de) * 1995-11-09 2004-02-15 Univ Massachusetts Wiederherstellung der gewebeoberfläche mit zusammensetzungen aus hydrogel-zellen

Also Published As

Publication number Publication date
JP2001513367A (ja) 2001-09-04
DK1003567T3 (da) 2003-12-01
AU724878B2 (en) 2000-10-05
EP1003567B1 (en) 2003-08-06
US6344488B1 (en) 2002-02-05
NO20000593L (no) 2000-03-29
EP1003567A1 (en) 2000-05-31
ATE246524T1 (de) 2003-08-15
NZ502919A (en) 2002-04-26
NO330580B1 (no) 2011-05-16
JP3634748B2 (ja) 2005-03-30
CA2212300A1 (en) 1999-02-04
AU6915098A (en) 1999-03-01
NO20000593D0 (no) 2000-02-04
IL134368A0 (en) 2001-04-30
ES2205471T3 (es) 2004-05-01
DE69816996T2 (de) 2004-07-22
PT1003567E (pt) 2003-12-31
WO1999007416A1 (en) 1999-02-18
DE69816996D1 (de) 2003-09-11

Similar Documents

Publication Publication Date Title
IL134368A (en) Temperature - controlled ph - dependent formation of ionic gels based on chitosan or derivatives thereof
CA2299687A1 (en) Temperature-controlled ph-dependant formation of ionic polysaccharide gels
US3956173A (en) Preparation of gels based on carrageenan
HUP9904115A2 (hu) Eljárás élelmiszer-adalékként felhasználható gyöngyök előállítására
US4318746A (en) Highly stable gel, its use and manufacture
CA2066252A1 (en) Gelling system
DE3064157D1 (en) Quick-set low methoxyl pectin composition
CA2273498A1 (en) Cross-linked protein gels and methods of making them
KR20170008823A (ko) 다공성 알긴산염계 에어로겔의 제조 방법
WO2001040370A3 (en) Ionically crosslinked hydrogels with adjustable gelation time
US4505935A (en) Protective layer on skin, mucous membrane or other body tissue
EP0207022A3 (en) Stable compositions
EP0157491A3 (en) Dry mix for preparation of pie and pastry fillings
JP2008184400A5 (xx)
KR20170037059A (ko) 하이드로겔 시트용 조성물, 하이드로겔 마스크 팩 및 이의 제조 방법
IE892637L (en) Liquid based composition comprising a gelling polysaccharide¹capable of forming a reversible gel and a method of¹preparing such composition
JP5107585B2 (ja) 低温充填ゼリー組成物とその製造方法
JP3605360B2 (ja) 活性およびバイオアベイラビリティーを保持するための熱−または酸素−不安定化合物の保護方法。
ES8504451A1 (es) Procedimiento para preparar geles acuosos claros y homogeneos
US2234383A (en) Dental impression composition
WO2002094034A3 (en) Alginate gel
JP3978356B2 (ja) 水性ゲル状組成物及び水性ゲルシート
CN113545476A (zh) 一种冷塑型凝胶剂组合物及含有该凝胶剂的食品
JPS62152465A (ja) ゲル状組成物
JP4955310B2 (ja) 皮膚貼付剤

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired